Mark Ragosa Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity
Mark Ragosa is CHIEF FINANCIAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 19,086 shares of KNSA, which is worth approximately $769,547. The most recent transaction as insider was on Apr 26, 2022, when has been sold 282 shares (Class A Common Share) at a price of $9.99 per share, resulting in proceeds of $2,817. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
19.1K
38.6%
3M change
16.87%
12M change
Total Value Held
$769,547
Mark Ragosa Transaction History
MR
Mark Ragosa
CHIEF FINANCIAL OFFICER
Hamilton, D0